Anti-LITAF/ PIG7/ SIMPLE monoclonal antibody

Anti-LITAF/ PIG7/ SIMPLE antibody for FACS & in-vivo assay

Target products collectionGo to LITAF/LITAF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0737-Ab-1/ GM-Tg-hg-MP0737-Ab-2Anti-Human LITAF monoclonal antibodyHuman
GM-Tg-rg-MP0737-Ab-1/ GM-Tg-rg-MP0737-Ab-2Anti-Rat LITAF monoclonal antibodyRat
GM-Tg-mg-MP0737-Ab-1/ GM-Tg-mg-MP0737-Ab-2Anti-Mouse LITAF monoclonal antibodyMouse
GM-Tg-cynog-MP0737-Ab-1/ GM-Tg-cynog-MP0737-Ab-2Anti-Cynomolgus/ Rhesus macaque LITAF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0737-Ab-1/ GM-Tg-felg-MP0737-Ab-2Anti-Feline LITAF monoclonal antibodyFeline
GM-Tg-cang-MP0737-Ab-1/ GM-Tg-cang-MP0737-Ab-2Anti-Canine LITAF monoclonal antibodyCanine
GM-Tg-bovg-MP0737-Ab-1/ GM-Tg-bovg-MP0737-Ab-2Anti-Bovine LITAF monoclonal antibodyBovine
GM-Tg-equg-MP0737-Ab-1/ GM-Tg-equg-MP0737-Ab-2Anti-Equine LITAF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0737-Ab-1/ GM-Tg-hg-MP0737-Ab-2; GM-Tg-rg-MP0737-Ab-1/ GM-Tg-rg-MP0737-Ab-2;
GM-Tg-mg-MP0737-Ab-1/ GM-Tg-mg-MP0737-Ab-2; GM-Tg-cynog-MP0737-Ab-1/ GM-Tg-cynog-MP0737-Ab-2;
GM-Tg-felg-MP0737-Ab-1/ GM-Tg-felg-MP0737-Ab-2; GM-Tg-cang-MP0737-Ab-1/ GM-Tg-cang-MP0737-Ab-2;
GM-Tg-bovg-MP0737-Ab-1/ GM-Tg-bovg-MP0737-Ab-2; GM-Tg-equg-MP0737-Ab-1/ GM-Tg-equg-MP0737-Ab-2
Products NameAnti-LITAF monoclonal antibody
Formatmab
Target NameLITAF
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LITAF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LITAF/ PIG7/ SIMPLE VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP002939human LITAF Lentivirus plasmid
    ORF Viral VectorvGMLP002939human LITAF Lentivirus particle
    ORF Viral VectorpGMLPm000655mouse Litaf Lentivirus plasmid
    ORF Viral VectorvGMLPm000655mouse Litaf Lentivirus particle


    Target information

    Target IDGM-MP0737
    Target NameLITAF
    Gene ID9516,56722,65161,711743,490004,101083562,520564,100033923
    Gene Symbol and Synonyms3222402J11Rik,EET-1,LITAF,N4WBP3,PIG7,SIMPLE,TBX1,TP53I7
    Uniprot AccessionQ99732,P0C0T0
    Uniprot Entry NameLITAF_HUMAN,LITAF_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000189067
    Target ClassificationN/A

    The target: LITAF, gene name: LITAF, also named as PIG7, SIMPLE, TP53I7. Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.